Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-Throughput Generation of Tumor Spheroids via Droplet Microfluidics for siRNA-Loaded Nanomedicine Assessment.

Advanced healthcare materials·2026
Same author

Droplet Digital CRISPR for Nucleic Acid Detection.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Ring-Shaped Open Microfluidic Platform Reveals Viscosity-Driven Mechanical Priming of Glioblastoma Cells.

ACS sensors·2025
Same author

Design advances in pinched flow fractionation for enhanced particle separation in microfluidics.

Lab on a chip·2025
Same author

Active Microfluidic Platforms for Particle Separation and Integrated Sensing Applications.

ACS sensors·2025
Same author

Microfluidic Femtosecond Laser-Induced Nucleation of Supersaturated Aqueous Sodium Chlorate Solutions.

ACS omega·2025

Related Experiment Video

Updated: Apr 22, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

5.5K

A Microwell Array Embedded Microfluidic Gradient Platform for Drug Screening on Tumor Spheroids.

Ling Liu1,2, Guoying Wang3, Ming Li1,2

  • 1School of Engineering, Macquarie University, Sydney, NSW, Australia.

Small (Weinheim an Der Bergstrasse, Germany)
|April 21, 2026
PubMed
Summary
This summary is machine-generated.

A new microfluidic gradient platform (MEG platform) enables high-throughput 3D tumor spheroid culture for drug testing. This system overcomes capacity limits, facilitating large-scale studies of tumor-stromal interactions and drug responses.

Keywords:
co‐culture spheroidhigh‐throughput drug evaluationmicrofluidic gradient platformsmicrowelltumor spheroid

More Related Videos

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
16:18

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Published on: November 20, 2011

11.2K
Analysis of Cancer Cell Invasion and Anti-metastatic Drug Screening Using Hydrogel Micro-chamber Array HMCA-based Plates
08:32

Analysis of Cancer Cell Invasion and Anti-metastatic Drug Screening Using Hydrogel Micro-chamber Array HMCA-based Plates

Published on: October 25, 2018

8.5K

Related Experiment Videos

Last Updated: Apr 22, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

5.5K
Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
16:18

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Published on: November 20, 2011

11.2K
Analysis of Cancer Cell Invasion and Anti-metastatic Drug Screening Using Hydrogel Micro-chamber Array HMCA-based Plates
08:32

Analysis of Cancer Cell Invasion and Anti-metastatic Drug Screening Using Hydrogel Micro-chamber Array HMCA-based Plates

Published on: October 25, 2018

8.5K

Area of Science:

  • Biomedical Engineering
  • Cancer Research
  • Microfluidics

Background:

  • Flow-based microfluidic gradient platforms are valuable for 3D tumor spheroid research due to precise control over concentration gradients.
  • Existing platforms often have limited spheroid culture capacity, hindering large-scale drug evaluation.

Purpose of the Study:

  • To develop a high-throughput microfluidic gradient platform with enhanced spheroid culture capacity.
  • To enable physiologically relevant spheroid culture and drug response assessment in both monocultures and co-cultures.

Main Methods:

  • Development of a microfluidic gradient platform with embedded high-density microwell arrays (MEG platform).
  • Flexible adjustment of spheroid culture capacity by modifying microwell array sheet size.
  • Assessment of stable gradient delivery under dynamic perfusion.
  • Evaluation of drug responses in monoculture and co-culture spheroids.

Main Results:

  • The MEG platform supports high-throughput, physiologically relevant spheroid culture with stable growth and morphology.
  • Stable gradient delivery was achieved under dynamic perfusion.
  • Co-culture spheroids demonstrated increased drug resistance compared to monocultures.
  • The platform facilitates tunable spheroid numbers for diverse experimental needs.

Conclusions:

  • The high-throughput MEG platform overcomes limitations of previous microfluidic gradient systems.
  • This advanced platform is suitable for large-scale drug testing and studying tumor-stromal interactions.
  • The findings highlight the potential of microfluidic technologies in personalized cancer therapy research.